Rapid cGMP manufacturing of COVID‐19 monoclonal antibody using stable CHO cell pools-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapid cGMP manufacturing of COVID‐19 monoclonal antibody using stable CHO cell pools

Published:2021-12-10 Issue:2 Volume:119 Page:663-666
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotech & Bioengineering

Author:

Agostinetto Rita¹,Rossi Mara¹,Dawson Jessica²,Lim Angela²,Simoneau Mirva H.³,Boucher Cyril³,Valldorf Bernhard⁴,Ross‐Gillespie Adin³,Jardine Joseph G.⁵⁶⁷,Sok Devin⁵⁶⁷,Burton Dennis R.⁵⁷⁸,Hassell Thomas⁶,Broly Hervé³,Palinsky Wolf³,Dupraz Philippe³,Feinberg Mark⁶,Dey Antu K.⁶^ORCID

Affiliation:

1. MerckSerono S.p.A, Guidonia di Montecello Italy

2. EMD Serono Billerica Massachusetts USA

3. Ares Trading SA/Merck SA Switzerland Aubonne Switzerland

4. Merck KGaA Darmstadt Germany

5. Department of Immunology and Microbiology The Scripps Research Institute La Jolla California USA

6. IAVI New York New York USA

7. IAVI, Neutralizing Antibody Center, The Scripps Research Institute La Jolla California USA

8. Ragon Institute of MGH, MIT and Harvard Cambridge Massachusetts USA

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.27995

Reference14 articles.

1. Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studies

2. Comparative study of therapeutic antibody candidates derived from mini-pool and clonal cell lines

3. A strategy to accelerate protein production from a pool of clones in Chinese hamster ovary cells for toxicology studies

4. Developing therapeutic monoclonal antibodies at pandemic pace

5. Accelerating patient access to novel biologics using stable pool-derived product for non-clinical studies and single clone-derived product for clinical studies

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The new frontier in CHO cell line development: From random to targeted transgene integration technologies;Biotechnology Advances;2024-10

2. Recombinant Antibody-Producing Stable CHOK1 Pool Stability Study;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2024-08-01

3. The history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras;mAbs;2024-07

4. Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool;Vaccines;2024-05-21

5. When will we have a clone? An industry perspective on the typical CLD timeline;Biotechnology Progress;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3